Safety and Side Effects Like all GLP-1 medications, both liraglutide and semaglutide can cause some gastrointestinal distress including nausea, diarrhea, vomiting, reflux and constipation
Key differences in titration approach All three medications use monthly dose increases
Subcutaneous semaglutide is also available at 2.4mg/weekly (brand name Wegovy) for chronic weight management in nondiabetics
The injectable medication could degrade, leading to adverse reactions like burning
We encourage patients to consult with our experienced healthcare providers to explore how Semaglutide GLP-1, alongside lifestyle changes, can be part of an effective strategy for achieving and maintaining a healthy weight
If your mornings are already rushed, or if you take other medications first thing in the morning, this routine requires some planning